Description
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Product Unit Size | Cost | Quantity | Stock |
|---|
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Cas No. | 1096708-71-2 |
|---|---|
| Purity | ≥98% |
| Formula | C17H12Cl2F3N7O2S |
| Formula Wt. | 506.30 |
| IUPAC Name | 2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5- chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide |
| Solubility | DMSO 100 mg/mL (197.51 mM) Ethanol 100 mg/mL (197.51 mM) Water Insoluble |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
http://clinicaltrials.gov/show/NCT01425008
c-Met inhibitor.
NSAID; NMDA inverse agonist, T-type Ca2+ and Cl...
GSK-3 inhibitor.
Endogenous peptide hormone; GnRH agonist.
p110β PI3K inhibitor.
Vitamin B6 derivative, antioxidant.
5-HT1A partial agonist, 5-HT2C antagonist.
PAK inhibitor.Smo inhibitor.
JAK1/2/3 inhibitor.
Antifungal antibiotic
Side chain attached to various taxanes.
Isothiocyanate found in cruciferous vegetables,...
Steroid; AR antagonist.
Carotenoid originally found in Capsicum. Color ...
ITC, erucin analog.
Endogenous peptide hormone fragment, involved i...
CSF-1R Inhibitor.
T-type calcium channel blocker
Vitamin A derivative, palmitic acid ester of re...